Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Last week patent highlights (11-05-09):
1. NON-AQUEOUS EXTRACTION OF [18F] FLUORIDE FROM CYCLOTRON TARGETS
2. Production Method of High Purity Silver Tetrafluoroborate
3. CONTINUOUS SILAZANE CLEAVAGE METHOD - especially for use in the production of molecular precursors for non-oxidic inorganic ceramics
4. PROCESS FOR PRODUCTION OF SILICON TETRAFLUORIDE, AND APPARATUS FOR THE PROCESS
5. Method for purifying silicon - for methods of purifying silicon methods for obtaining purified silicon
6. CALCIUM-SILICATE BASED SLAG FOR TREATMENT OF MOLTEN SILICON
7. Synthesis Of High Quality Carbon Single-Walled Nanotubes
8. Method for growing carbon nanowalls - on a base material is disclosed
9. CARBON FIBROUS STRUCTURE - method for forming a carbon fibrous structure having a granular part to which a plurality of carbon fibers are bound
10. PROCESS FOR PRODUCING SUPPORTED RUTHENIUM OXIDE AND PROCESS FOR PRODUCING CHLORINE
11. Hydrogen Production Using Ammonia Borane
12. HYDROGEN STORAGE MATERIAL AND PREPARATION THEREOF
13. Device for the Generation of Hydrogen Gas by Dehydrogenation of Hydrocarbon Fuels
14. ZEOLITE MEMBRANES FOR HYDROGEN GAS PRODUCTION AND METHOD OF PRODUCING HYDROGEN GAS USING THE ZEOLITE MEMBRANES
15. Adsorbent - absorbent of ZSM-5 zeolite ion-exchanged with copper ion characterized in that at least 60% or more of the copper sites in the copper
16. TADG-15: an extracellular serine protease overexpressed in carcinomas
17. TUMOR VASCULATURE MARKERS AND METHODS OF USE THEROF
18. Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
19. USE OF PYRENE TO CARRY NON-PEPTIDE AGENTS ACROSS THE BLOOD BRAIN BARRIER
20. NECROSIS AVID TRACER AGENT - method for obtaining an image of ischemic infarcted or necrotic tissue in a subject
21. IN VIVO IMAGING AGENTS FOR MET RECEPTOR TYROSINE KINASE
22. RADIOTRACERS FOR IMAGING P-GLYCOPROTEIN FUNCTION
23. Compositions and Methods for The Treatment of Cancer
24. TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
25. Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same
26. RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS
27. Sanitizing Composition and Method of Preparation
28. RED BLOOD CELL-DERIVED VESICLES AS A NANOPARTICLE DRUG DELIVERY SYSTEM
29. RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
30. Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
31. TOOTH POWDER CONTAINING ELVAN AS RADIATION SOURCE OF FAR INFRARED RAY
32. Novel crosslinked polymeric substrates methods of preparation and end use applications of the substrates
33. Bactericide having selectivity to cariogenic bacterium, and a method for sterilization of cariogenic bacterium
34. TOOTH ENAMEL DISSOLUTION INHIBITOR - object of the present invention is to provide a tooth enamel dissolution inhibitor that can inhibit the dissolution
35. Depigmenting or Brigthening Cosmetic Composition at Least One Oxazolin as an Active Ingredient
36. COSMETIC USE OF A C-GLYCOSIDE DERIVATIVE IN COMBINATION WITH ASCORBIC ACID
37. COMPOSITION FOR HAIR - It is an object of the present invention to provide a composition for hair which comprises a hydrophobic ingredient although it
38. Hair Care Compositions - are disclosed which comprise a silicone polyurethane polymer, an ester, and a fluorosilicone
39. COSMETIC COMPOSITION COMPRISING ONE OR MORE VINYLFORMAMIDE/VINYLFORMAMINE COPOLYMERS AND ONE OR MORE THICKENING POLYMERS
40. Hair Care Compositions for Preventing Oxidative Damage to Hair, Methods of Use, and Methods of Marketing Such Compositions
41. Low viscosity, high molecular weight linear random-block silicone polyalkyleneoxide copolymers
42. Ant Eradication Composition and Method - composition and method for eradicating ants is provided wherein the composition includes borax, sugar and yeast
43. GALL MIDGE PHEROMONE MIXTURE - pheromone composition for attracting male Hessian fly Mayetiola destructor
44. Methods for Controlling Molluscs - Novel materials for controlling molluscs such as snails and slugs using carbohydrates including celluloses
45. Immunotherapeutic Formulations with Interleukin-2-Neutralizing Capacity
46. HEPATITIS C VIRUS INHIBITORS - having the general formula STR00001 are disclosed
47. Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
48. INHIBITORS OF ASPARTYL PROTEASE - novel class of sulfonamides which are aspartyl protease inhibitors
49. Therapeutic agent for infections, and treatment method using the same
50. Hepatitis C Virus Inhibitors - having the general formula STR00001 are disclosed
51. INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY
52. METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
53. 2-CARBOXY THIOPHENE DERIVATIVES AS ANTI VIRAL AGENTS
54. HEPATITIS C VIRUS INHIBITORS - are disclosed having the general formula: STR00001 wherein R
55. DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS
56. Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
57. Compositions And Methods For Producing Fermentation Products And Residuals
58. PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF
59. USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION
60. Methods And Kits For The Treatment Of Inflammatory Bowel Disorder Conditions
61. Materials and Methods Relating to Cell Based Therapies
62. Method of culturing vascular smooth muscle cells, culture device and medical material obtained by the culture
63. Stem Cells For Treating Lung Diseases - The invention is compositions and methods for treating lung diseases and conditions using mesenchymal stem cells
64. B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE
65. RETINAL PIGMENT EPITHELIAL STEM CELLS - retinal pigment epithelial stem cell isolated from a posterior region of the retinal pigment epithelium of an
66. Combined Regulation of Neural Cell Production
67. Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use
68. DPH2 GENE DELETION MUTANT AND USES THEREOF
69. VECTOR ENCODING HUMAN GLOBIN GENE AND USE THEREOF IN TREATMENT OF HEMOGLOBINOPATHIES
70. Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same
71. COMPOSITION FOR TOPICAL TREATMENT OF ACNE
72. Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
73. Migraine tonic - This invention is proposing a combination of a system of migraine headache remedies from non-prescription pharmaceuticals in the form
74. COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
75. ANTIOXIDANT FOR USE IN COSMETIC, MEDICATED AND PHARMACEUTICAL PREPARATIONS
76. Compositions and methods to treat urinary incontinence
77. PRODUCTION AND USE OF HUMAN BUTYRYLCHOLINESTERASE
78. Human Phospholipases - The invention provides human lipid metabolism enzymes and polynucleotides which identify and encode LME
79. NOVEL GENE ENCODING A DNA REPAIR ENZYME AND METHODS OF USE THEREOF
80. DEMETHYLATION AND INACTIVATION OF PROTEIN PHOSPHATASE 2A
81. ADAMTS13 GENES AND PROTEINS AND VARIANTS, AND THERAPEUTIC COMPOSITIONS AND METHODS OF UTILIZING THE SAME
82. Methods for the Identification of Modulators of OSGPR114 or OSGPR78 Activity, and their use in the Treatment of Disease
83. ILT3 POLYPEPTIDES AND USES THEREOF - method for inhibiting the rejection of transplanted islet cells comprising administering to the subject a
84. NUCLEOSIDE PHOSPHONATE DERIVATIVES - The present invention discloses compounds of formula or or pharmaceutically acceptable salts esters
85. ATTENUATION OF HYPOXIA INDUCED CARDIOVASCULAR DISORDERS
86. Antibodies to OPGL - Antibodies that interact with osteoprotegerin ligand are described
87. Co-Administration of a Thrombolytic and an Anti-CD18 Antibody in Stroke
88. Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
89. Use of CD25 binding molecules in steroid-resistant patients
90. CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
91. Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor
92. CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are
93. Inhibition of urokinase-type plasminogen activator (uPA) activity
94. METHODS FOR TREATING INFLAMMATION - Provided are methods and compositions for reducing airway hyperresponsiveness and other inflammatory diseases
95. Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
96. Combination anti-cancer therapy - method for treating tumors or tumor metastases in a patient comprising administering to said patient simultaneously or
97. UL16 BINDING PROTEIN 4 - ULBP4, a novel member of the ULBP family has been isolated and characterized
98. IL-31 RECEPTOR ANTIBODIES - Novel polypeptides polynucleotides encoding the polypeptides and related compositions and methods are disclosed for zcytor17
99. CHLAMYDIA PNEUMONIAE POLYNUCLEOTIDES AND USES THEREOF
100. Method of treatment and Agents useful for same
previous page next page
Archives
09-04-08 07-02-09 10-16-08 05-28-09 12-25-08 10-01-09 09-11-08 07-09-09 02-26-09 08-13-0911-20-08 07-30-09 12-18-08 09-10-09 11-27-08 04-16-09 06-11-09 01-08-09 05-14-09 11-06-08
08-27-09 09-24-09 10-15-09 06-18-09 09-17-09 03-26-09 01-15-09 10-30-08 06-25-09 12-04-08
10-08-09 08-06-09 02-19-09 06-04-09 10-23-08 02-12-09 04-23-09 09-25-08 05-21-09 01-29-09
03-05-09 12-11-08 03-19-09 04-30-09 01-01-09 10-22-09 10-29-09 07-23-09 07-16-09 05-07-09
02-05-09 03-12-09 10-02-08 04-09-09 09-03-09 08-20-09 04-02-09 10-09-08 11-13-08 01-22-09
08-28-08 09-18-08 08-21-08